Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 11:37 am Sale |
2024-12-31 | 13G | Perspective Therapeutics, Inc. CATX |
JANUS HENDERSON GROUP PLC JHG |
17,839 0.000% |
-4,781,513 (-99.63%) |
Filing History |
| 2025-02-14 10:26 am Sale |
2024-12-31 | 13G | Perspective Therapeutics, Inc. CATX |
Avidity Partners Management LP | 2,841,024 4.200% |
-749,402 (-20.87%) |
Filing History |
| 2024-11-14 6:14 pm Purchase |
2024-09-30 | 13G | Perspective Therapeutics, Inc. CATX |
Avidity Partners Management LP | 3,590,426 5.300% |
3,590,426 (New Position) |
Filing History |
| 2024-11-14 4:05 pm Purchase |
2024-09-30 | 13G | Perspective Therapeutics, Inc. CATX |
Commodore Capital LP | 3,350,000 4.960% |
3,350,000 (New Position) |
Filing History |
| 2024-11-14 10:24 am Purchase |
2024-09-30 | 13G | Perspective Therapeutics, Inc. CATX |
JANUS HENDERSON GROUP PLC JHG |
4,799,352 7.100% |
4,799,352 (New Position) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Perspective Therapeutics, Inc. CATX |
BLACKROCK INC BLK |
4,039,974 6.000% |
0 (Unchanged) |
Filing History |
| 2024-11-07 09:24 am Purchase |
2024-11-06 | 13G | Perspective Therapeutics, Inc. CATX |
FMR CORP | 9,496,225 14.083% |
3,991,403 (+72.51%) |
Filing History |
| 2024-11-07 09:12 am Purchase |
2024-11-06 | 13G | Perspective Therapeutics, Inc. CATX |
FMR CORP | 5,504,822 8.164% |
5,504,822 (New Position) |
Filing History |
| 2024-10-24 2:02 pm Purchase |
2024-09-30 | 13G | Perspective Therapeutics, Inc. CATX |
BLACKROCK INC BLK |
4,039,974 6.000% |
4,039,974 (New Position) |
Filing History |
| 2024-04-19 4:05 pm Purchase |
2024-04-11 | 13G | Perspective Therapeutics, Inc. CATX |
Commodore Capital LP | 3,890,667 6.600% |
3,890,667 (New Position) |
Filing History |
| 2024-03-08 11:22 am Purchase |
2024-03-06 | 13D | Perspective Therapeutics, Inc. CATX |
Lantheus Holdings Inc. LNTH |
11,677,339 19.900% |
6,043,104 (+107.26%) |
Filing History |
| 2024-02-05 7:18 pm Sale |
2023-12-31 | 13G | Perspective Therapeutics, Inc. CATX |
Johnson Frances | 1,677,908 5.900% |
-90,000 (-5.09%) |
Filing History |
| 2024-02-05 5:35 pm Sale |
2023-12-31 | 13G | Perspective Therapeutics, Inc. CATX |
Schultz Michael K | 1,677,908 5.900% |
-90,000 (-5.09%) |
Filing History |
| 2024-02-01 07:38 am Purchase |
2024-01-22 | 13D | Perspective Therapeutics, Inc. CATX |
Lantheus Holdings Inc. LNTH |
5,634,236 10.740% |
5,634,236 (New Position) |
Filing History |
| 2023-09-18 9:20 pm Purchase |
2023-02-03 | 13G | Perspective Therapeutics, Inc. CATX |
Schultz Michael K | 1,767,908 6.300% |
1,767,908 (New Position) |
Filing History |
| 2023-09-18 8:02 pm Purchase |
2023-02-03 | 13G | Perspective Therapeutics, Inc. CATX |
Johnson Frances | 1,767,908 6.300% |
1,767,908 (New Position) |
Filing History |